Suanfarma Suanfarma

X

Find the latest Drugs in Development and Pipeline Prospector News of Kalypso Wellness Centers.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Kalypso Wellness Centers
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
6625 Wooldridge Rd., Suite 101 Corpus Christi, TX 78414
Telephone
Telephone
(361) 356-6441
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

ELE-Ket+ and ELE-Psilo+ are expected to enter Phase II clinical trials for the adjunctive treatment of major depressive disorder at the end of 2021. Under the terms of the agreement, Eleusis will acquire Kalypso and its intellectual property in an all-stock transaction.


Lead Product(s): ELE-Psilo+

Therapeutic Area: Psychiatry/Psychology Product Name: ELE-Psilo+

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: Eleusis

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition December 14, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY